In this Innovation Spotlight, Emmanuel Naouri, associate director of Product Management, NGS Benchtop Systems at Illumina, discusses how the MiSeq i100 Series of sequencers was designed to meet the ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

The company recently announced the MiSeq i100 series ... and competitive positioning in the global sequencing market. Illumina's emphasis on reducing the total cost of sequencing, rather than ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of new partnerships or products, namely the MiSeq i100 benchtop sequencer.

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Additionally, the long-read sequencing market ... instrument sales and higher consumables pull-through. Illumina’s introduction of the MiSeq i100 series demonstrates the company’s commitment ...

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Illumina has established a strong foothold in the market. The company’s product portfolio includes high-throughput sequencers like the NovaSeq X series, as well as lower-throughput instruments such as ...